Insights

Why GreenLight Biosciences Stock Is Crushing It Today

What happened

GreenLight Biosciences Holdings (NASDAQ: GRNA) is absolutely crushing it today, with the stock skyrocketing 42% as of 11:37 a.m. ET on Thursday. The company didn’t announce any new developments. Instead, today’s huge gain reflects continued strong momentum from a big announcement earlier this week.

On Aug. 1, GreenLight announced that it and Samsung Biologics had successfully completed the first commercial-scale engineering run for their messenger RNA (mRNA) partnership. This run paves the way for the two companies to crank up their production of mRNA COVID-19 vaccines. 

So what

GreenLight’s recent surge was badly needed. But it doesn’t erase the previous steep decline for the biotech stock. Even after this week’s huge jump, GreenLight’s shares remain down more than 50% year to date.

Investors are understandably excited about the latest development though. GreenLight and Samsung went from the conceptualization stage to a commercial-scale production run in less than two years. Importantly, the companies will also be able to produce all components of GreenLight’s mRNA vaccines at one facility. 

But GreenLight still has a long way to go. Its mRNA products targeting human health remain in pre-clinical testing. The company’s agricultural product candidates are also only in early development.

Now what

GreenLight hopes to advance its mRNA booster vaccine into clinical testing later this year. However, it will still lag far behind rivals such as Pfizer and Moderna. Even if GreenLight’s clinical testing of its COVID-19 vaccine is successful, there’s no guarantee that the company will be able to carve out significant market share.

Keith Speights has positions in Pfizer. The Motley Fool recommends Moderna Inc. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate
Popular

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here To Get Started
EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here For More Info